Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 25265494

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2014 Nov 13
First author
Larkin J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):683. doi: 10.1038/nrclinonc.2014.183.
    note
    Source null
    related pmid
    25331181
    relationship
    Comment in
  2. citation
    N Engl J Med. 2014 Nov 13;371(20):1929-30. doi: 10.1056/NEJMe1411158.
    note
    Source null
    related pmid
    25390744
    relationship
    Comment in

Authors and identifiers

  1. name
    Larkin J
    type
    Author
  2. name
    Ascierto PA
    type
    Author
  3. name
    Dréno B
    type
    Author
  4. name
    Atkinson V
    type
    Author
  5. name
    Liszkay G
    type
    Author
  6. name
    Maio M
    type
    Author
  7. name
    Mandalà M
    type
    Author
  8. name
    Demidov L
    type
    Author
  9. name
    Stroyakovskiy D
    type
    Author
  10. name
    Thomas L
    type
    Author
  11. name
    de la Cruz-Merino L
    type
    Author
  12. name
    Dutriaux C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Larkin J
    type
    Author
  2. name
    Ascierto PA
    type
    Author
  3. name
    Dréno B
    type
    Author
  4. name
    Atkinson V
    type
    Author
  5. name
    Liszkay G
    type
    Author
  6. name
    Maio M
    type
    Author
  7. name
    Mandalà M
    type
    Author
  8. name
    Demidov L
    type
    Author
  9. name
    Stroyakovskiy D
    type
    Author
  10. name
    Thomas L
    type
    Author
  11. name
    de la Cruz-Merino L
    type
    Author
  12. name
    Dutriaux C
    type
    Author
bibliography ids
  1. nci-bib-76757554c1adb7c5ed55c3f5
book metadata
content sha256
61cf18a779365fdfe06f7e9595e101a326cf21958701d1f7d057e3b7cec0f183
document type
citation
dois
  1. 10.1056/NEJMoa1408868
electronic publication date
display
2014 Sep 29
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25265494
immutable id
pubmed:25265494@61cf18a779365fdfe06f7e9595e101a326cf21958701d1f7d057e3b7cec0f183
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
20
name
The New England journal of medicine
nlm unique id
0255562
pages
1867-76
volume
371
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):683. doi: 10.1038/nrclinonc.2014.183.
    note
    Source null
    related pmid
    25331181
    relationship
    Comment in
  2. citation
    N Engl J Med. 2014 Nov 13;371(20):1929-30. doi: 10.1056/NEJMe1411158.
    note
    Source null
    related pmid
    25390744
    relationship
    Comment in
outcomes validated
false
pmid
25265494
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
02b97231f605d202874c8eb303a34375faa8f6fcbbffad98cdcb5048e4fe76ff
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Nov 13
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25265494/
title
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Preserved source evidence · Independent clinical review pending · Not medical advice